Baffi TR,Van AN,Zhao W,Mills GB,Newton AC,Kinase C Quality AC .2019 .Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer. Mol. Cell, 74(2) : 378-392.
Newton Brognard J,AC Brognard J .2008 .PHLiPPing the switch on Akt and protein kinase C signaling. Trends. Endocrinol. Metab., 19(6) : 223-230.
Brognard J¸ Sierecki E,Gao T,Newton AC .2007 .PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell., 25(6) : 917-931.
Burley SK .2018 .Ligand validation for the protein data bank. Acta Cryst., 74(1) : 323.
Chen M,Pratt CP,Zeeman ME,Schultz N,Taylor BS,O'Neill A,Castillo-Martin M,Nowak DG,Naguib A,Grace DM,Murn J,Navin N,Atwal GS,Sander C,Gerald WL,Cordon-Cardo C,Newton AC,Carver BS,Trotman LC .2011 .Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell, 20(2) : 173-186.
Yeates TO Colovos C .1993 .Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9) : 1511-1519.
Dallakyan S,Olson AJ .2015 .Small-molecule library screening by docking with PyRx. Methods. Mol. Biol, 1263 : 243-250.
Dong X,Yang Z X .2011 .Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-step Atomic-level Energy Minimization. Biophysical Journal, 101(10) : 2525-2534.
Gao T,Furnari F,Newton AC .2005 .PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis and suppresses tumor growth. Mol. Cell., 18(1) : 13-24.
Gentile F,Deriu MA,Licandro G,Prunotto A,Danani A,Tuszynski JA .2015 .Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations. , 20(5) : 8316-8340.
Humphrey W,Dalke A,Schulten K A .1996 .Visual molecular dynamics. J. Mol. Graph, 14(1) : 33-38.
Jiménez J,Skalic M,Martinez-Rosell G,De Fabritiis G G .2018 .KDEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks. J. Chem, 58(2) : 287-296.
Karnoub AE,Dash AB,Vo AP,Sullivan A,Brooks MW,Bell GW,Richardson AL,Polyak K,Tubo R,Weinberg RA .2007 .Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449(7162) : 557-563.
Katsenelson KC,Stender JD,Kawashima AT,Lorden G,Uchiyama S,Nizet V,Glass CK,Newton AC .2019 .PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife, 8 : e48609.
Laskowski RA,MacArthur MW,Moss DS,Thornton JM .1993 .PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 26(2) : 283-291.
Li X,Stevens PD,Yang H,Gulhati P,Wang W,Evers BM,Gao T .2013 .The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Oncogene, 32(4) : 471-478.
Liu J,Weiss HL,Rychahou P,Jackson LN,Evers BM,Gao T .2009 .Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis. Oncogene, 28(7) : 994-1004.
Maehama T,Dixon JE .1998 .The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger. J Biol Chem., 273(22) : 13375-13378.
Majumder PK,Yeh JJ,George DJ,Febbo PG,Kum J,Xue Q,Bikoff R,Ma H,Kantoff PW,Golub TR,Loda M,Sellers WR M .2003 .Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc. Natl. Acad. Sci. USA, 100(13) : 7841-7846.
Patael-Karasik Y,Daniely M,Gotlieb WH,Ben-Baruch G,Schiby J,Barakai G,Goldman B,Aviram A,Friedman E .2000 .Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer. Genet, 121(1) : 26-32.
Rakha EA,Green AR,Powe DG,Roylance R,Ellis IO .2006 .Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer, 45(6) : 527-535.
Talantov D,Mazumder A,Yu JX,Briggs T,Jiang Y,Backus J,Atkins D,Wang Y .2005 .Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer. Res., 11(20) : 7234-7242.
Taylor BS,Schultz N,Hieronymus H,Gopalan A,Xiao Y,Carver BS,Arora VK,Kaushik P,Cerami E,Reva B,Antipin Y,Mitsiades N,Landers T,Dolgalev I,Major JE,Wilson M,Socci ND,Lash AE,Heguy A,Eastham JA,Scher HI,Reuter VE,Scardino PT,Sander C,Sawyers CL,Gerald WL .2010 .Integrative genomic profiling of human prostate cancer. Cancer Cell, 18(1) : 11-22.
Vyas VK,Ukawala RD,Ghate M,Chintha C M .2012 .Homology modeling a fast tool for drug discovery: Current perspectives. Indian J. Pharm. Sci., 74(1) : 1-17.
Wallace AC,Laskowski RA,Thornton JM .1995 .LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein. Eng., 8(2) : 127-134.
Waterhouse A,Bertoni M,Bienert S,Studer G,Tauriello G,Gumienny R,Heer FT,de Beer TAP,Rempfer C,Bordoli L,Lepore R,Schwede T .2018 .SWISSMODEL: homology modelling of protein structures and complexes. Nucleic Acids Res, 46(1) : 296-303.
Wong KK,Engelman JA,Cantley LC .2010 .Targeting the PI3K signaling pathway in cancer. Curr. Opin. Genet, 20(1) : 87-89.
Yan R,Chuang HC,Kapuriya N,Chou CC,Lai PT,Chang HW,Yang CN,Kulp SK,Chen CS .2015 .Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors. J Med, 58(5) : 2290-2298.
Yang J,Cron P,Thompson V,Good VM,Hess D,Hemmings BA,Barford D BA .2002 .Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell., 9(6) : 1227-1240.